Melinda Magyari, MD, PhD

Danish Multiple Sclerosis Center and Danish Multiple Sclerosis Registry, Copenhagen University Hospital Rigshospitalet, Denmark

Poster(s):

• Tu136 - Intravenous Ofatumumab Treatment of Multiple Sclerosis and Related Disorders: An Observational Study
  Tuesday, June 21, 2022

  6:15 PM – 7:45 PM PT